Maggie Qin

Maggie Qin is a seasoned professional in the biopharmaceutical industry, currently serving as a Quality Control Manager at BlueRock Therapeutics since October 2020. With extensive experience in analytical development, Maggie has successfully managed analytical science teams and overseen quality control processes in various roles, including Manager of Analytical Science at Evolve Biologics and Supervisor of the Plasma Protein Analytical Group at Therapure Biopharma Inc. A skilled expert in analytical method development, qualification, and compliance with regulatory guidelines, Maggie has also held senior technical and research positions at notable organizations, including SQI Diagnostics and QSV Biologics. Maggie holds an M.Sc. in Biochemistry and a B.Sc. in Microbiology from Shandong University, complemented by completion of the Management Essential Program at the University of Toronto.